Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
Sodium Chloride
Overview
What is Amphenol-40?
This preparation is designed solely for parenteral use only after addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injection.
0.9% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, isotonic solution of sodium chloride and water for injection. Each mL contains sodium chloride 9 mg. It contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single-dose containers to dilute or dissolve drugs for injection. 0.308 mOsmol/mL (calc.). 0.9% Sodium Chloride Injection, USP contains no preservatives. The solution may contain hydrochloric acid and/or sodium hydroxide for pH adjustment. pH 5.3 (4.5 to 7.0).
Sodium Chloride, USP is chemically designated NaCl, a white crystalline compound freely soluble in water.
The glass container is a Type I borosilicate glass and meets the requirements of the powdered glass test according to the USP standards.
The semi-rigid vial is fabricated from a specially formulated polyolefin. It is a copolymer of ethylene and propylene. The safety of the plastic has been confirmed by tests in animals according to USP biological standards for plastic containers. The container requires no vapor barrier to maintain the proper drug concentration.
What does Amphenol-40 look like?
What are the available doses of Amphenol-40?
Sorry No records found.
What should I talk to my health care provider before I take Amphenol-40?
Sorry No records found
How should I use Amphenol-40?
This parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.
The volume of the preparation to be used for diluting or dissolving any drug for injection, is dependent on the vehicle concentration, dose and route of administration as recommended by the manufacturer. This parenteral should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
What interacts with Amphenol-40?
Sorry No Records found
What are the warnings of Amphenol-40?
Sorry No Records found
What are the precautions of Amphenol-40?
Consult the manufacturer's instructions for choice of vehicle, appropriate dilution or volume for dissolving the drugs to be injected, including the route and rate of injection.
Inspect reconstituted (diluted or dissolved) drugs for clarity (if soluble) and freedom from unexpected precipitation or discoloration prior to administration.
Pregnancy Category C
Pediatric Use:
Drug Interactions
Some drugs for injection may be incompatible in a given vehicle, or when combined in the same vehicle or in a vehicle containing benzyl alcohol. Consult with pharmacist, if available.
Use aseptic technique for single or multiple entry and withdrawal from all containers.
When diluting or dissolving drugs, mix thoroughly and use promptly.
Do not store reconstituted solutions of drugs for injection unless otherwise directed by the manufacturer of the solute.
Do not use unless the solution is clear and seal intact. Do not reuse single-dose containers, discard unused portion.
What are the side effects of Amphenol-40?
Reactions which may occur because of this solution, added drugs or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection and extravasation.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate countermeasures, and if possible, retrieve and save the remainder of the unused vehicle for examination.
What should I look out for while using Amphenol-40?
What might happen if I take too much Amphenol-40?
Use only as a diluent or solvent. This parenteral preparation is unlikely to pose a threat of carbohydrate, sodium chloride or fluid overload except possibly in neonates or very small infants. In the event these should occur, re-evaluate the patient and institute appropriate corrective measures. See and .
How should I store and handle Amphenol-40?
Store at 20° to 25°C (68 to 77°F);excursions permitted to 15° to 30° C (59° to 86°F) [See USP Controlled Room Temperature]. Protect from moisture. Dispense in tight, child-resistant container (USP).0.9% Sodium Chloride Injection, USP is supplied in the following:Store at controlled room temperature 20 to 25°C (68 to 77°F) [See USP Controlled Room Temperature.]Instructions for Use of the Syringe SystemsInstructions for using the Carpuject Syringe are available with the reusable Carpuject Holder, List 2049-02.Revised:9/2015Manufactured by:Assembled and Distributed byFor questions or comments: 0.9% Sodium Chloride Injection, USP is supplied in the following:Store at controlled room temperature 20 to 25°C (68 to 77°F) [See USP Controlled Room Temperature.]Instructions for Use of the Syringe SystemsInstructions for using the Carpuject Syringe are available with the reusable Carpuject Holder, List 2049-02.Revised:9/2015Manufactured by:Assembled and Distributed byFor questions or comments: 0.9% Sodium Chloride Injection, USP is supplied in the following:Store at controlled room temperature 20 to 25°C (68 to 77°F) [See USP Controlled Room Temperature.]Instructions for Use of the Syringe SystemsInstructions for using the Carpuject Syringe are available with the reusable Carpuject Holder, List 2049-02.Revised:9/2015Manufactured by:Assembled and Distributed byFor questions or comments: 0.9% Sodium Chloride Injection, USP is supplied in the following:Store at controlled room temperature 20 to 25°C (68 to 77°F) [See USP Controlled Room Temperature.]Instructions for Use of the Syringe SystemsInstructions for using the Carpuject Syringe are available with the reusable Carpuject Holder, List 2049-02.Revised:9/2015Manufactured by:Assembled and Distributed byFor questions or comments: 0.9% Sodium Chloride Injection, USP is supplied in the following:Store at controlled room temperature 20 to 25°C (68 to 77°F) [See USP Controlled Room Temperature.]Instructions for Use of the Syringe SystemsInstructions for using the Carpuject Syringe are available with the reusable Carpuject Holder, List 2049-02.Revised:9/2015Manufactured by:Assembled and Distributed byFor questions or comments: 0.9% Sodium Chloride Injection, USP is supplied in the following:Store at controlled room temperature 20 to 25°C (68 to 77°F) [See USP Controlled Room Temperature.]Instructions for Use of the Syringe SystemsInstructions for using the Carpuject Syringe are available with the reusable Carpuject Holder, List 2049-02.Revised:9/2015Manufactured by:Assembled and Distributed byFor questions or comments: 0.9% Sodium Chloride Injection, USP is supplied in the following:Store at controlled room temperature 20 to 25°C (68 to 77°F) [See USP Controlled Room Temperature.]Instructions for Use of the Syringe SystemsInstructions for using the Carpuject Syringe are available with the reusable Carpuject Holder, List 2049-02.Revised:9/2015Manufactured by:Assembled and Distributed byFor questions or comments: 0.9% Sodium Chloride Injection, USP is supplied in the following:Store at controlled room temperature 20 to 25°C (68 to 77°F) [See USP Controlled Room Temperature.]Instructions for Use of the Syringe SystemsInstructions for using the Carpuject Syringe are available with the reusable Carpuject Holder, List 2049-02.Revised:9/2015Manufactured by:Assembled and Distributed byFor questions or comments:
Clinical Information
Chemical Structure
No Image foundClinical Pharmacology
Sodium chloride in water dissociates to provide sodium (Na+) and chloride (Cl) ions. These ions are normal constituents of the body fluids (principally extracellular) and are essential for maintaining electrolyte balance.
The distribution and excretion of sodium (Na+) and chloride (Cl) are largely under the control of the kidney which maintains a balance between intake and output.
The small volume of fluid and amount of sodium chloride provided by 0.9% Sodium Chloride Injection, USP when used only as an isotonic vehicle for parenteral injection of drugs, is unlikely to exert a significant effect on fluid and electrolyte balance except possibly in neonates and very small infants.
Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. Average normal adult daily requirement ranges from two to three litres (1.0 to 1.5 litres each for insensible water loss by perspiration and urine production).
Water balance is maintained by various regulatory mechanisms. Water distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (Na+) plays a major role in maintaining physiologic equilibrium.
Non-Clinical Toxicology
When given concurrently the following drugs may interact with thiazide diuretics:Consult the manufacturer's instructions for choice of vehicle, appropriate dilution or volume for dissolving the drugs to be injected, including the route and rate of injection.
Inspect reconstituted (diluted or dissolved) drugs for clarity (if soluble) and freedom from unexpected precipitation or discoloration prior to administration.
Pregnancy Category C
Pediatric Use:
Drug Interactions
Some drugs for injection may be incompatible in a given vehicle, or when combined in the same vehicle or in a vehicle containing benzyl alcohol. Consult with pharmacist, if available.
Use aseptic technique for single or multiple entry and withdrawal from all containers.
When diluting or dissolving drugs, mix thoroughly and use promptly.
Do not store reconstituted solutions of drugs for injection unless otherwise directed by the manufacturer of the solute.
Do not use unless the solution is clear and seal intact. Do not reuse single-dose containers, discard unused portion.
Reactions which may occur because of this solution, added drugs or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection and extravasation.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate countermeasures, and if possible, retrieve and save the remainder of the unused vehicle for examination.
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Review
Read user comments about the side effects, benefits, and effectiveness of losartan oral.
Overall User Ratings
516Total User Reviews
User Reviews
Learn about
User Reviews
Professional
Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72Tips
Tips
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).